Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease

Identifying which neuropsychological measures detect early cognitive changes associated with Alzheimer disease (AD) brain pathology would be helpful clinically for the diagnosis of early AD and for the design of clinical trials. We evaluated which neuropsychological measures in our cognitive battery...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neurobiol Aging
Main Authors: Schindler, Suzanne E., Jasielec, Mateusz S., Weng, Hua, Hassenstab, Jason J., Grober, Ellen, McCue, Lena M., Morris, John C., Holtzman, David M., Xiong, Chengjie, Fagan, Anne M.
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5505233/
https://ncbi.nlm.nih.gov/pubmed/28482211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neurobiolaging.2017.04.004
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares